Clinical Trials
7 trialsNCT02943642 2026-05-18
Resimmune®
Virogen Biotechnology Inc.
Phase 2 Withdrawn
NCT03563040 2021-09-08
PROMPT
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Withdrawn
NCT03742804 2019-12-18
Study Of Intratumoral G100 In Cutaneous T Cell Lymphoma
Yale University
Phase 2 Withdrawn
NCT00621036 2018-11-26
Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma
University of Texas Southwestern Medical Center
Phase 2 Withdrawn
NCT01652014 2016-07-14
Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies
Rutgers, The State University of New Jersey
Phase 2 Withdrawn
NCT01843998 2015-06-04
Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL)
Medical College of Wisconsin
Phase 2 Withdrawn
NCT00969085 2012-09-07
Trial of Curcumin in Cutaneous T-cell Lymphoma Patients
M.D. Anderson Cancer Center
Phase 2 Withdrawn